Ozen S.The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol. 2002;16:411-425.
3.
Yi ES, Colby TVWegener’s granulomatosis. Semin Diagn Pathol. 2001;18:34-46.
4.
Frosch M., Foell D.Wegener granulomatosis in childhood and adolescence. Eur J Pediatr. 2004;163(8):425-34.
5.
Brouwer E., Huitema MG, Klok PA, et al. Antimyeloper oxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med. 1993;177:905-914.
6.
Kallenberg CG , Rarok A., Stegeman CA, Limburg PCNew insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun Rev. 2002;1:61-66.
7.
Patry YC, Trewick DC, Gregoire M., et al. Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2001;12:1764-1768.
8.
Grisaru S., Yuen GW, Miettunen PM, Hamiwka LAIncidence of Wegener’s granulomatosis in children. J Rheumatol. 2010;37:440-442.
9.
Stegmayr BG, Gothefors L., Malmer B., Müller Wiefel DE, Nilsson K., Sundelin B.Wegener granulomatosis in children and young adults. A case study of ten patients . Pediatr Nephrol. 2000;14:208-213.
10.
Watts RA, Al-Taiar A., Scott DG, Macgregor AJPrevalence and incidence of Wegener’s granulomatosis in the UK general practice research database. Arthritis Rheum. 2009;61:1412-1416.
11.
Akikusa JD, Schneider R., Harvey EA, et al. Clinical features and outcome of pediatric Wegener’s granulomatosis . Arthritis Rheum. 2007;57:837-844.
12.
Klinger H.Grenzformen der periarteritis Nodosa. Frankfurt Z Pathol. 1931;42:455-480.
Wegener F.Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arterien Systems und der Nieren. Beitr Pathol Anat Allg Pathol . 1939:36-68.
15.
Ozen S., Pistorio A., Iusan SM, et al. EULAR/PRINTO/ PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis.2010;69:798-806.
16.
Cabral DA, Uribe AG, Benseler S., et al. Classification, presentation, and initial treatment of Wegener’s granulomatosis in childhood. Arthritis Rheum. 2009;60:3413-3424.
17.
Stein SL, Miller LC, Konnikov N.Wegener’s granulomatosis: case report and literature review. Pediatr Dermatol. 1998;15:352-356.
18.
Bolton-Maggs PH, Pasi KJHaemophilias A and B. Lancet . 2003;361:1801-1809.
19.
Rosen FS, Mackay I.The immunology series comes to an end. N Engl J Med. 2001;345:1343-1344.
20.
Franchini M. , Gandini G., Di Paolantonio T., Mariani G.Acquired hemophilia A: a concise review. Am J Hematol. 2005;80:55-63.
21.
Andre S., Meslier Y., Dimitrov JD, et al. A cellular viewpoint of anti-FVIII immune response in hemophilia A. Clin Rev Allergy Immunol. 2009;37:105-113.
22.
Franchini M. , Lippi G.Acquired factor VIII inhibitors. Blood. 2008;112:250-255.
23.
Keogh KA, Wylam ME, Stone JH, Specks U.Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52: 262-268.
24.
Patel AM, Lehman TJRituximab for severe refractory pediatric Wegener granulomatosis. J Clin Rheumatol. 2008;14:278-280.
25.
Aries PM, Hellmich B., Voswinkel J., et al. Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis . 2006;65:853-858.
26.
Matic G., Michelsen A., Hofmann D., et al. Three cases of C-ANCA-positive vasculitis treated with immunoadsorption: possible benefit in early treatment. Ther Apher. 2001;5:68-72.